You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Zepbound ® (tirzepatide) injection
2.5 mg/ 5 mg/ 7.5 mg/ 10 mg/ 12.5 mg/ 15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How do I get Zepbound® (tirzepatide) vials or multidose KwikPens?
Zepbound vials and multi-dose KwikPens are available in all strengths exclusively through LillyDirect's self-pay pharmacy channel for patients with a prescription from their healthcare provider.
See important safety information, including boxed warning, in the attached prescribing information.
Zepbound Availability on LillyDirect
Eli Lilly and Company has created a self-pay pharmacy component of LillyDirect® where patients with a valid, on-label, electronic prescription from the health care provider of their choice can purchase Zepbound vials or multi-dose KwikPens.
Patients can also order the single dose pen through LillyDirect's insurance pharmacy component. Tirzepatide is only currently available through LillyDirect under the Zepbound brand name.
To learn more about LillyDirect, please visit: https://www.lilly.com/lillydirect/medicines/zepbound
Zepbound List Price at LillyDirect
Distributing the Zepbound via LillyDirect’s self-pay pharmacy channel offers transparent pricing for the Zepbound vials and multi-dose KwikPens, cutting out extra costs to pass savings directly to patients. This option helps adults with obesity access the medicine they need, including those
Distributing Zepbound via LillyDirect ensures patients and providers can trust they are receiving genuine Lilly medicine.1,2
For information about the cost or price of Zepbound, please visit https://www.lillypricinginfo.com/zepbound for English or https://www.lillypricinginfo.com/es/zepbound for Spanish.
Enclosed Prescribing Information
References
1Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity. Press release. Eli Lilly and Company; August 27, 2024. Accessed February 23, 2026. https://investor.lilly.com/news-releases/news-release-details/lilly-releases-zepboundr-tirzepatide-single-dose-vials-expanding
2Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen; February 23, 2026. Accessed February 23, 2026. https://investor.lilly.com/news-releases/news-release-details/zepbound-tirzepatide-most-prescribed-weight-management
Date of Last Review: February 23, 2026